ABSTRACT
We report a case of rapid regression of extensive posterior capsule neovascularization in a 67-year-old diabetic male patient, who developed posterior capsule opacity with neovascularization one year post cataract surgery, after a single injection of intravitreal bevacizumab [Avastin] followed by neodymium:YAG capsulotomy. Rapid regression of the posterior capsule neovascularization, and visual improvement was observed 9 days after the intervention. Posterior capsulotomy was performed successfully without bleeding. Prior to posterior capsulotomy, intravitreal bevacizumab can result in rapid and dramatic regression of posterior capsule neovascularization
Subject(s)
Humans , Male , Aged , Antibodies, Monoclonal , Angiogenesis Inhibitors , Vascular Endothelial Growth Factor A , Treatment OutcomeABSTRACT
To report and describe the clinical presentation of malignant glaucoma after Ahmed glaucoma valve implant [AGVI] in 2 patients. Chart review of 2 patients who developed malignant glaucoma after AGVI at the King Khaled Eye Specialist Hospital, Riyadh. Both patients developed high intraocular pressure [IOP] associated with axial shallowing of the anterior chamber despite patent iridotomies and normal posterior segment anatomy following AGVI surgery. Both of them did not respond to medical or laser treatment. However, the anterior chamber deepened and the IOP was controlled in both cases after pars plana vitrectomy and anterior chamber reformation. Malignant glaucoma can develop after AGVI. Successful clinical outcomes can be achieved with posterior segment surgery